Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial.

P, Sargos; S, Chabaud; I, Latorzeff; N, Magné; A, Benyoucef; S, Supiot; D, Pasquier; MS, Abdiche; O, Gilliot; P, Graff-Cailleaud; M, Silva; P, Bergerot; P, Baumann; Y, Belkacemi; D, Azria; M, Brihoum; M, Soulié; P, Richaud

doi:10.1016/s1470-2045(20)30454-x

Public

Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial.

Shared by NobleBlocks on Oct 1, 2020 • 12:00 AM UTC

Authors:

Sargos P

Chabaud S

Latorzeff I

Abstract

Background Adjuvant radiotherapy reduces the risk of biochemical progression in prostate cancer patients after radical prostatectomy. We aimed to compare adjuvant versus early salvage radiotherapy after radical prostatectomy, combined with short-term hormonal therapy, in terms of oncological outcome...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!